Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trial.

Saved in:
Bibliographic Details
Title: Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trial.
Authors: Mikic N; Department of Neurosurgery, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Lukacova S; Department of Clinical Medicine, Aarhus University.; Department of Oncology, Aarhus University Hospital., Skjøth-Rasmussen J; Department of Neurosurgery, Rigshospitalet.; Department of Clinical Medicine, Copenhagen University., Poulsen FR; Department of Neurosurgery, Odense University Hospital.; Clinical Institute BRIDGE (Brain Research InterDisciplinary Guided Excellence), University of Southern Denmark., Hauerberg J; Department of Neurosurgery, Rigshospitalet., Laursen RJ; Department of Neurosurgery, Aalborg University Hospital., Ettrup KS; Department of Neurosurgery, Aalborg University Hospital., Møller S; Department of Oncology, Rigshospitalet., Haslund CA; Department of Oncology, Aalborg University Hospital., Dahlrot RH; Department of Oncology, Odense University Hospital.; Department of Clinical Research, University of Southern Denmark., Cortnum SOS; Department of Neurosurgery, Aarhus University Hospital., Sindby AK; Department of Neurosurgery, Aarhus University Hospital., Von Oettingen G; Department of Neurosurgery, Aarhus University Hospital., Valentin JB; Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University., Solheim O; Department of Neurosurgery, St. Olavs University Hospital.; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology., Solheim TS; Department of Oncology, St. Olavs University Hospital.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology., Sørensen JCH; Department of Neurosurgery, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Wong ET; Division of Hematology/Oncology, Department of Medicine, Brown University Health & Rhode Island Hospital, Rhode Island., Korshøj AR; Department of Neurosurgery, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University.
Source: Neuro-oncology advances [Neurooncol Adv] 2025 Nov 20; Vol. 7 (1), pp. vdaf245. Date of Electronic Publication: 2025 Nov 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdaf245